1649 articles in this topic
New research reveals how chronic inflammation varies by person, paving the way for personalized interventions to combat age-related diseases.
Men with Klinefelter syndrome (XXY) show reduced epigenetic aging compared to typical XY males, challenging assumptions about chromosome disorders.
Leading researchers identify key challenges in validating aging biomarkers for clinical use, emphasizing need for longitudinal studies.
New research explores how epigenetic modifications control the aging process and potential therapeutic targets.
Targeting CXCR4 protein improved lung function and reduced heart damage in early COPD mouse models, suggesting new therapeutic approach.
New study reveals mitochondrial NAD+ concentration, not total cellular levels, determines how fast the liver can regenerate after injury.
Comprehensive review reveals emerging clinical evidence for NAD+ precursors in treating age-related diseases and cognitive decline.
Review reveals progress in using stem cell-derived heart cells to treat heart failure, but survival and safety hurdles remain.
DNA methylation patterns reveal that patients with faster biological aging experience more rapid vision loss from glaucoma.
Study of 1,014 adults finds GrimAge epigenetic clock most accurately links biological aging to physical performance from age 20-104.
Analysis of 1,942 people shows GrimAge and GrimAge2 epigenetic clocks outperform other aging biomarkers at predicting mortality.
Leading NAD+ researcher Dr. Charles Brenner shares breakthrough insights on cellular energy, aging, and practical longevity strategies.
